Trial Search Results
Use of PET/MR Imaging in Chronic Pain
The investigators are studying the ability of PET/MR imaging (using the PET tracer [18F]FDG) to objectively identify and characterize pain generators in patients suffering from chronic pain.
Stanford is currently accepting patients for this trial.
Collaborator: GE Healthcare
- Drug: [18F]FDG
- Device: PET/MRI
- Age 18 years or older.
- Chronic pain lasting greater than 2 months. For example: Low back pain, sciatica,
complex regional pain syndrome, peripheral nerve injury, fibromyalgia, neuropathy,
osteoarthritis, cancer pain, persistent post-operative pain, and migraine.
- Provides informed consent
- On a typical day, pain level of at least 4/10 on a 0-10 Comparative Pain Scale
- Covid Vaccination status: Vaccinated or unvaccinated subjects who received a negative
test result from the Covid test within 72 hours of the scan.
- Pregnant or nursing
- Non-English speaker
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study